Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,396,035
  • Shares Outstanding, K 189,880
  • Annual Sales, $ 2,419 M
  • Annual Income, $ 167,650 K
  • 60-Month Beta 0.32
  • Price/Sales 5.48
  • Price/Cash Flow 47.46
  • Price/Book 3.05
Trade BMRN with:

Options Overview Details

View History
  • Implied Volatility 27.68% ( -0.97%)
  • Historical Volatility 60.85%
  • IV Percentile 36%
  • IV Rank 20.30%
  • IV High 48.42% on 08/05/24
  • IV Low 22.40% on 11/03/23
  • Put/Call Vol Ratio 1.73
  • Today's Volume 4,923
  • Volume Avg (30-Day) 5,095
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 79,962
  • Open Int (30-Day) 63,438

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.58
  • Number of Estimates 11
  • High Estimate 0.71
  • Low Estimate 0.50
  • Prior Year 0.26
  • Growth Rate Est. (year over year) +123.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
68.83 +3.35%
on 09/17/24
94.85 -25.00%
on 08/20/24
-18.39 (-20.54%)
since 08/16/24
3-Month
68.83 +3.35%
on 09/17/24
94.85 -25.00%
on 08/20/24
-13.01 (-15.46%)
since 06/18/24
52-Week
68.83 +3.35%
on 09/17/24
99.56 -28.55%
on 12/14/23
-17.46 (-19.71%)
since 09/18/23

Most Recent Stories

More News
Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives

The urgent need for innovative technologies to accelerate the development of life-saving %Cancer therapies has never been more critical. With millions of lives and billions of dollars at stake, the potential...

MRK : 118.64 (+0.30%)
NVS : 115.97 (+0.23%)
KTRA : 0.1750 (-8.42%)
RKV.VN : 0.085 (-5.56%)
RHHBY : 39.5250 (+0.50%)
XBIT : 7.50 (+1.49%)
BMRN : 71.14 (+0.84%)
AZN : 78.58 (+0.06%)
Is Vertex Pharmaceuticals Stock Outperforming the Nasdaq?

Vertex Pharmaceuticals has outperformed the Nasdaq over the past year, and analysts remain moderately bullish about the stock's prospects.

VRTX : 474.16 (-1.48%)
$NASX : 17,573.30 (-0.31%)
BMRN : 71.14 (+0.84%)
Stock Index Futures Tread Water as Investors Brace for Fed Minutes and Powell’s Speech

September S&P 500 E-Mini futures (ESU24) are up +0.01%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.09% this morning as market participants geared up for the release of the minutes of the...

ESU24 : 5,635.75 (-0.06%)
NQU24 : 19,425.00 (-0.07%)
ZIM : 19.12 (-2.94%)
AMD : 148.29 (-1.68%)
MCD : 292.03 (-0.59%)
HPQ : 34.53 (+0.29%)
LOW : 256.63 (-0.04%)
MDT : 88.13 (-0.56%)
KEYS : 150.21 (-0.19%)
TOL : 150.14 (-0.35%)
AS : 14.85 (-0.27%)
TTNP : 5.66 (-3.25%)
CSX, Caterpillar rise; ZoomInfo, Teradata fall, Tuesday, 8/6/2024

Stocks that traded heavily or had substantial price changes on Tuesday: CSX, Caterpillar rise; ZoomInfo, Teradata fall

YUMC : 34.82 (-0.23%)
LCID : 3.64 (-3.70%)
BMRN : 71.14 (+0.84%)
PLTR : 36.38 (-0.19%)
CSX : 34.05 (-0.06%)
TDC : 28.64 (-0.66%)
ZI : 10.35 (-2.36%)
BioMarin: Q2 Earnings Snapshot

BioMarin: Q2 Earnings Snapshot

BMRN : 71.14 (+0.84%)
4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Plain-as-day bargains can still be found, even with the innovation-fueled Nasdaq Composite powering to a fresh all-time high.

COMP : 6.39 (-2.29%)
$NASX : 17,573.30 (-0.31%)
META : 537.95 (+0.30%)
FVRR : 25.29 (+1.73%)
BMRN : 71.14 (+0.84%)
WDC : 64.42 (-2.23%)
4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Opportunistic investors can still find bargains, even with the Nasdaq Composite up 49% since the start of 2023.

COMP : 6.39 (-2.29%)
$NASX : 17,573.30 (-0.31%)
INTC : 20.77 (-3.26%)
BMRN : 71.14 (+0.84%)
S : 24.29 (-2.57%)
PYPL : 73.12 (+1.88%)
BioMarin: Q1 Earnings Snapshot

BioMarin: Q1 Earnings Snapshot

BMRN : 71.14 (+0.84%)
4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Although the Nasdaq Composite is galloping to record highs, amazing deals among growth stocks can still be uncovered.

COMP : 6.39 (-2.29%)
$NASX : 17,573.30 (-0.31%)
PYPL : 73.12 (+1.88%)
FVRR : 25.29 (+1.73%)
BMRN : 71.14 (+0.84%)
GOOGL : 159.81 (+0.31%)
GOOG : 160.81 (+0.33%)
BioMarin: Q4 Earnings Snapshot

BioMarin: Q4 Earnings Snapshot

BMRN : 71.14 (+0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder),...

See More

Key Turning Points

3rd Resistance Point 74.66
2nd Resistance Point 73.15
1st Resistance Point 71.85
Last Price 71.14
1st Support Level 69.04
2nd Support Level 67.53
3rd Support Level 66.23

See More

52-Week High 99.56
Fibonacci 61.8% 87.82
Fibonacci 50% 84.20
Fibonacci 38.2% 80.57
Last Price 71.14
52-Week Low 68.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar